Literature DB >> 29222384

13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2018.

.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29222384     DOI: 10.2337/dc18-S013

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  102 in total

Review 1.  The National Glycohemoglobin Standardization Program: Over 20 Years of Improving Hemoglobin A1c Measurement.

Authors:  Randie R Little; Curt Rohlfing; David B Sacks
Journal:  Clin Chem       Date:  2018-12-05       Impact factor: 8.327

2.  Association of Gestational Diabetes and Type 2 Diabetes Exposure In Utero With the Development of Type 2 Diabetes in First Nations and Non-First Nations Offspring.

Authors:  Brandy A Wicklow; Elizabeth A C Sellers; Atul K Sharma; Kristine Kroeker; Nathan C Nickel; Wanda Philips-Beck; Garry X Shen
Journal:  JAMA Pediatr       Date:  2018-08-01       Impact factor: 16.193

Review 3.  Nutritional Supplementation for the Prevention and/or Treatment of Gestational Diabetes Mellitus.

Authors:  Jasmine F Plows; Clare M Reynolds; Mark H Vickers; Philip N Baker; Joanna L Stanley
Journal:  Curr Diab Rep       Date:  2019-08-01       Impact factor: 4.810

4.  A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes.

Authors:  Linda A Barbour; Christina Scifres; Amy M Valent; Jacob E Friedman; Thomas A Buchanan; Donald Coustan; Kjersti Aagaard; Kent L Thornburg; Patrick M Catalano; Henry L Galan; William W Hay; Antonio E Frias; Kartik Shankar; Rebecca A Simmons; Robert G Moses; David A Sacks; Mary R Loeken
Journal:  Am J Obstet Gynecol       Date:  2018-06-28       Impact factor: 8.661

Review 5.  Inpatient Glycemic Management of the Pregnant Patient.

Authors:  Tiffany Yeh; Michele Yeung; Felicia A Mendelsohn Curanaj
Journal:  Curr Diab Rep       Date:  2018-08-15       Impact factor: 4.810

Review 6.  Pregnancy in women with diabetic nephropathy.

Authors:  Donatella Spotti
Journal:  J Nephrol       Date:  2018-11-15       Impact factor: 3.902

Review 7.  Optimal Obstetric Management for Women with Diabetes: the Benefits and Costs of Fetal Surveillance.

Authors:  Ukachi N Emeruwa; Chloe Zera
Journal:  Curr Diab Rep       Date:  2018-09-07       Impact factor: 4.810

8.  Maternal urinary cadmium, glucose intolerance and gestational diabetes in the New Hampshire Birth Cohort Study.

Authors:  Megan E Romano; Lisa G Gallagher; Brian P Jackson; Emily Baker; Margaret R Karagas
Journal:  Environ Res       Date:  2019-09-07       Impact factor: 6.498

9.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

Review 10.  Oral Agents for the Treatment of Gestational Diabetes.

Authors:  Matthew M Finneran; Mark B Landon
Journal:  Curr Diab Rep       Date:  2018-09-28       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.